Peptide administration for lung fibrosis treatment using formulation based on medusa technology. develop a sustained release formulation os p144 or p17, loquid or freeze-dried form, for subcutaneous administration route and carry on preclinical and clinical trials.
3D reconstruction of the shape and bone mineral density distribution of the spine from 2D DXA images
Therapeutic use of epigenetic modulators in oncological and neurodegenerative disease
Prognostic miRNA-based test for left ventricular remodelling after acute myocardial infarction.
A tailored and rational approach for treating cancer patients with a YAP-TEAD inhibitor
Mid-Infrared Laser Assisted Bioprinting
MPEG-G Enabled Genome Analysis Pipeline
The objective is to design and develop a histamine h3 receptor inverse agonist as a novel type of drug for use in the treatment of alzheimer's disease, obesity and/or epilepsy.
Development of a natural component based on clays, diatomite and seaweeds which will replace the current growth promoters and the fight against mycotoxicosis in animal feed.
Development of new products to replace the subtherapeutic use of antibiotics and alternatives to the coccidiostatics currently used in farm livestock food.